Who Qualifies for GLP-1 Weight Loss Medication in Florida?

One of the most common questions patients ask when they first reach out to CORAL is some version of: "Do I even qualify for this medication?" The answer depends on a few clinical factors — primarily your BMI, your medical history, and which medication is being considered.

Here is a clear breakdown of the eligibility criteria for GLP-1 weight loss medications in Florida.

The FDA-Approved Criteria

The FDA has established specific criteria for GLP-1 medications approved for chronic weight management. While physicians can prescribe off-label based on clinical judgment, these are the standard guidelines:

Semaglutide (Wegovy) and Oral Semaglutide for Weight Loss

You qualify if you have:

• BMI ≥ 30 (obesity), OR
• BMI ≥ 27 (overweight) with at least one weight-related health condition

Weight-related conditions that meet the criteria include:

• Type 2 diabetes or prediabetes
• High blood pressure (hypertension)
• High cholesterol or triglycerides (dyslipidemia)
• Obstructive sleep apnea
• Cardiovascular disease
• Non-alcoholic fatty liver disease (NAFLD/MASLD)
• Osteoarthritis related to excess weight
• Polycystic ovary syndrome (PCOS)

Tirzepatide (Zepbound)

The criteria are the same:

• BMI ≥ 30, OR
• BMI ≥ 27 with a weight-related comorbidity

Liraglutide (Saxenda)

Same BMI thresholds:

• BMI ≥ 30, OR
• BMI ≥ 27 with a weight-related comorbidity

What Is BMI and How Do You Calculate It?

BMI (Body Mass Index) is calculated as weight in kilograms divided by height in meters squared. In more practical terms:

BMI = (weight in pounds × 703) / (height in inches × height in inches)

Here are some reference points:

| Height | BMI 27 Weight | BMI 30 Weight |

|---|---|---|

| 5'2" | 148 lbs | 164 lbs |

| 5'4" | 157 lbs | 174 lbs |

| 5'6" | 167 lbs | 186 lbs |

| 5'8" | 178 lbs | 197 lbs |

| 5'10" | 188 lbs | 209 lbs |

| 6'0" | 199 lbs | 221 lbs |

| 6'2" | 211 lbs | 234 lbs |

The Limitations of BMI

BMI is a screening tool, not a definitive measure of health. It has well-documented limitations:

BMI does not distinguish between fat and muscle. A muscular athlete at 5'10" and 210 pounds has a BMI of 30.1 despite having a healthy body fat percentage. Conversely, someone with the same BMI but little muscle mass and a high body fat percentage has a very different health profile.

BMI does not account for fat distribution. Visceral fat (around the organs) is significantly more dangerous than subcutaneous fat (under the skin). Two people with the same BMI can have very different risk profiles based on where they carry their weight.

BMI thresholds were developed primarily using data from white populations. Research shows that health risks associated with excess weight can begin at lower BMI levels in certain populations — particularly South Asian, East Asian, and Southeast Asian populations, where metabolic complications often appear at BMIs below 27.

What this means for you: BMI is the starting point for determining eligibility, not the whole story. A physician should also consider your waist circumference, body composition, metabolic markers, family history, and overall health profile.

Do You Need a Prior Weight Loss Attempt?

This depends on the context:

For a physician prescribing directly (including telehealth): No. There is no FDA requirement that you must have "tried and failed" diet and exercise before being prescribed a GLP-1 medication. A physician who determines that medication is clinically appropriate can prescribe it.

For insurance coverage: Most insurance plans that cover GLP-1 medications require documentation of prior weight loss attempts — typically showing that a structured diet and exercise program did not produce adequate results over a defined period (usually 3-6 months). This is an insurance requirement, not a medical one.

For compounded semaglutide through telehealth: Insurance is typically not involved, so prior weight loss attempt documentation is not required. The physician evaluates your medical history and determines whether medication is appropriate.

Medical Contraindications

Not everyone who meets the BMI criteria should take a GLP-1 medication. Contraindications include:

Absolute contraindications:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple endocrine neoplasia syndrome type 2 (MEN 2)
• Known hypersensitivity to semaglutide, tirzepatide, or any formulation component
• Pregnancy or plans to become pregnant (discontinue 2 months before planned pregnancy for semaglutide, 1 month for tirzepatide)

Relative contraindications (require careful evaluation):

• History of pancreatitis
• Severe gastroparesis
• History of eating disorders (particularly bulimia or binge eating disorder — requires careful discussion)
• Severe kidney disease
• Active gallbladder disease
• Type 1 diabetes (GLP-1 medications can be used in some cases but require specialized management)

What About Type 2 Diabetes?

If you have type 2 diabetes, GLP-1 medications may be prescribed for diabetes management regardless of your BMI. In fact, semaglutide (Ozempic) and tirzepatide (Mounjaro) were first approved for type 2 diabetes before their weight management indications.

If you have both type 2 diabetes and obesity, a GLP-1 medication addresses both conditions simultaneously — which is one reason this medication class has become so widely prescribed.

Age and Gender Considerations

Minimum age: Wegovy is approved for patients 12 years and older. Zepbound is approved for adults 18 and older. Pediatric GLP-1 prescribing follows specific guidelines that differ from adult protocols.

Maximum age: There is no upper age limit, but elderly patients (75+) require careful consideration of muscle mass preservation, fall risk, and nutritional status. Weight loss in older adults can accelerate sarcopenia and frailty if not managed carefully.

Gender: There are no gender-specific eligibility differences for GLP-1 medications. However, women who are pregnant, breastfeeding, or planning pregnancy should not take these medications.

The Evaluation Process at CORAL

At CORAL, eligibility determination is a medical conversation, not a checkbox exercise. When you schedule a consultation, Dr. Kim reviews:

1. Your current weight and BMI — starting point for eligibility
2. Your medical history — including any conditions that might affect medication choice or safety
3. Your current medications — to check for interactions
4. Your weight history — patterns of gain, previous attempts, contributing factors
5. Your goals — what you are trying to achieve and why
6. Any contraindications — making sure the medication is safe for you specifically

This evaluation happens during a telehealth visit — no need to come into an office. If you qualify and medication is appropriate, a prescription can be sent to a pharmacy the same day.

What If You Do Not Meet BMI Criteria?

If your BMI is below 27 (or below 30 without a comorbidity), GLP-1 medications may not be appropriate for you — or may not be covered by insurance even if prescribed. In this case:

• A physician may still prescribe off-label if there is clinical justification
• The focus may shift to other interventions: nutritional counseling, exercise programming, hormonal evaluation, or addressing underlying conditions that affect weight
• You may be closer to goal than you think — sometimes the issue is body composition (too much fat, too little muscle) rather than total weight

The Bottom Line

Most adults with a BMI ≥ 30 — or ≥ 27 with a weight-related health condition — qualify for GLP-1 weight loss medication. The eligibility criteria are broader than many patients expect, and the evaluation process through telehealth is straightforward.

If you are unsure whether you qualify, the fastest way to find out is to have a physician review your specific situation. Do not assume you do not qualify based on self-assessment — many patients who thought they were "not heavy enough" actually meet the criteria.

---

Not sure if you qualify for GLP-1 medication? CORAL offers quick, physician-led telehealth evaluations. [Check your eligibility at coral.clinic/start](https://coral.clinic/start).